Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the safety and efficacy of sustained-release quetiapine fumarate (Seroquel®) in the treatment of patients with Acute Bipolar Mania for 3 weeks.

PLEASE NOTE: Seroquel SR and Seroquel XR refer to the same formulation. The SR designation was changed to XR after consultation with FDA.


Clinical Trial Description

n/a


Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Treatment


Related Conditions & MeSH terms


NCT number NCT00422123
Study type Interventional
Source AstraZeneca
Contact
Status Completed
Phase Phase 3
Start date January 2007
Completion date July 2007

See also
  Status Clinical Trial Phase
Recruiting NCT05206747 - Ottawa Sunglasses at Night for Mania Study N/A
Completed NCT00534222 - Unraveling the Relation of Patient's Profile and Therapeutical Effects of Atypicals, Including Quetiapine Effect N/A
Completed NCT00140179 - Valnoctamide in Mania Phase 3
Completed NCT01237379 - Peroxisomal Defects and Familial Risk for Bipolar Disorder N/A
Completed NCT01315028 - Bipolar Intervention Study: Cognitive Interpersonal Therapy N/A
Completed NCT00254488 - Treatment of Bipolar Mania in Older Adults Phase 4
Completed NCT00560079 - Efficacy of Allopurinol and Dypiridamole in Acute Mania Phase 4
Completed NCT00518947 - Pharmacotherapy of Treatment-Resistant Mania Phase 3
Recruiting NCT05444907 - Deep Brain Stimulation-Induced Mania in Parkinson's Disease
Enrolling by invitation NCT02360267 - Pediatric Bipolar Registry
Completed NCT01092221 - Allopurinol for Mania: A Randomized Trial Administering Allopurinol vs. Placebo as add-on to Mood Stabilizers and/or Antipsychotics in Patients in a Bipolar Manic Episode Phase 3
Completed NCT00521365 - Effectiveness of Quetiapine XR on the Control of Symptoms of Manic Phase of Bipolar Disorder. Phase 4
Completed NCT01191918 - The Efficacy and Safety of AChE Inhibitor Donepezil As Adjunctive Treatment to Mood Stabilizers in Acute Mania Phase 4
Completed NCT01541605 - Methylphenidate for the Treatment of Acute Mania Phase 3
Completed NCT00893581 - Multimodal Neuroimaging of Treatment Effects in Adolescent Mania N/A
Completed NCT00208195 - Depakote ER Therapy for Mania Comorbid With Substance Abuse Phase 4
Completed NCT00181922 - Ziprasidone for the Treatment of Mania in Children and Adolescents With Bipolar Disorder Phase 4
Completed NCT00181935 - Risperidone Versus Olanzapine for Mania in Preschool Children 4 to 6 Years of Age With Bipolar Disorder Phase 4
Active, not recruiting NCT05703711 - Combining mHealth and Nurse-delivered Care to Improve the Outcomes of People With Serious Mental Illness in West Africa N/A
Completed NCT00917501 - Neurochemical Effects of Omega-3 Fatty Acids in Adolescents at Risk for Mania Phase 2